Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype

被引:13
作者
Moermans, C. [1 ,5 ]
Damas, K. [2 ]
Guiot, J. [1 ]
Njock, M. S. [1 ,3 ,4 ,5 ]
Corhay, J. L. [1 ]
Henket, M. [1 ]
Schleich, F. [1 ]
Louis, R. [1 ]
机构
[1] CHU Liege, Dept Pneumol Allergol, B-4000 Liege, Belgium
[2] Haute Ecole Prov Liege HEPL, Liege, Belgium
[3] CHU Liege, Dept Rheumatol, B-4000 Liege, Belgium
[4] CHU Liege, Dept Gastroenterol, B-4000 Liege, Belgium
[5] Univ Liege, GIGA Res Ctr, I3 Grp, Liege, Belgium
关键词
Airway obstructive diseases; Alarmins; Sputum; IL-23; IL-36;
D O I
10.1016/j.cyto.2021.155421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Alarmins ((IL-25, IL-33 and thymic stromal lymphopoietin (TSLP)) are known to promote Th2 inflammation and could be associated with eosinophilic airway infiltration. They may also play a role in airway remodeling in chronic airway obstructive diseases such as asthma and chronic obstructive pulmonary disease (COPD). IL-23 and IL-36 were shown to mediate the neutrophilic airway inflammation as seen in chronic airway obstructive diseases. Objectives: The purpose of this project was to determine the expression and the production of these cytokines from induced sputum (IS) in patients with chronic airway obstructive diseases including asthmatics and COPD. The relationship of the mediators with sputum inflammatory cellular profile and the severity of airway obstruction was assessed. Methods: The alarmins (IL-25, IL-33 and TSLP) as well as IL-23 and IL-36 concentrations were measured in IS from 24 asthmatics and 20 COPD patients compared to 25 healthy volunteers. The cytokines were assessed by ELISA in the IS supernatant and by RT-qPCR in the IS cells. Results: At protein level, no difference was observed between controls and patients suffering from airway obstructive diseases regarding the different mediators. IL-36 protein level was negatively correlated with sputum eosinophil and appeared significantly decreased in patients with an eosinophilic airway inflammation compared to those with a neutrophilic profile and controls. At gene level, only IL-36, IL-23 and TSLP were measurable but none differed between controls and patients with airway obstructive diseases. IL-36 and IL-23 were significantly increased in patients with an neutrophilic inflammatory profile compared to those with an eosinophilic inflammation and were correlated with sputum neutrophil proportions. None of the mediators were linked to airway obstruction. Conclusions: The main finding of our study is that patients with eosinophilic airway inflammation exhibited a reduced IL-36 level which could make them more susceptible to airway infections as IL-36 is implicated in antimicrobial defense. This study showed also an implication of IL-36 and IL-23 in airway neutrophilic inflammation in chronic airway obstructive diseases.
引用
收藏
页数:8
相关论文
共 61 条
  • [1] Treatable traits: toward precision medicine of chronic airway diseases
    Agusti, Alvar
    Bel, Elisabeth
    Thomas, Mike
    Vogelmeier, Claus
    Brusselle, Guy
    Holgate, Stephen
    Humbert, Marc
    Jones, Paul
    Gibson, Peter G.
    Vestbo, Jorgen
    Beasley, Richard
    Pavord, Ian D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) : 410 - 419
  • [2] [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341
  • [3] Induced Sputum in Asthma: From Bench to Bedside
    Bakakos, P.
    Schleich, F.
    Alchanatis, M.
    Louis, R.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (10) : 1415 - 1422
  • [4] Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
    Barnes, Peter J.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2018, 18 (07) : 454 - 466
  • [5] DAMPs, PAMPs and alarmins: all we need to know about danger
    Bianchi, Marco E.
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (01) : 1 - 5
  • [6] Bjerregaard A., 2017, RESP MED
  • [7] Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma
    Bochkov, Y. A.
    Hanson, K. M.
    Keles, S.
    Brockman-Schneider, R. A.
    Jarjour, N. N.
    Gern, J. E.
    [J]. MUCOSAL IMMUNOLOGY, 2010, 3 (01) : 69 - 80
  • [8] Eosinophilic airway inflammation in nonallergic asthma
    Brusselle, Guy G.
    Maes, Tania
    Bracke, Ken R.
    [J]. NATURE MEDICINE, 2013, 19 (08) : 977 - 979
  • [9] Epithelial Interleukin-25 Is a Key Mediator in Th2-High, Corticosteroid-Responsive Asthma
    Cheng, Dan
    Xue, Zheng
    Yi, Lingling
    Shi, Huimin
    Zhang, Kan
    Huo, Xiaorong
    Bonser, Luke R.
    Zhao, Jianping
    Xu, Yongjian
    Erle, David J.
    Zhen, Guohua
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (06) : 639 - 648
  • [10] Targeting the interleukin pathway in the treatment of asthma
    Chung, Kian Fan
    [J]. LANCET, 2015, 386 (9998) : 1086 - 1096